A year ago, software engineers Dima Goncharov and Colin Elsinga released Metriport: a personal data companion for discovering patterns in your life.
“Gone are the days where you track periods in one app, mood in another, and do daily journaling in another separate app,” Elsinga declared to Techcouver last February. “With Metriport, you can do it all in one app, and then find correlations between the things you’re tracking.”
The Vancouver-born startup—originally described as a “Swiss Army Knife of personal tracking”—joined YC’s S22 program over the summer.
It was an “opportunity to take our product to another level while learning and working with some of the brightest entrepreneurs in the world,” according to the company.
As a result Techcouver knew to put Metriport on its annual list of Homegrown B.C. Startups to Watch.
And as it turns out, during the stay at YC, Metriport discovered a major pain point in US healthcare that its product may be able to help solve.
Metriport unveiled this week it has raised US$2.4 million from YC plus several other interested parties: Triple Impact Capital, Nueterra Capital, Leonis Investissement, Zillionize, VentureSouq, Stonks, MyAsiaVC, and a roster of angel investors, according to a report from TechCrunch.
“The fundraise allowed us to grow our team and accelerate our engineering velocity, which is great since we have a lot of product to build,” Elsinga informed TC. “Additionally, it allows us to pave our way through the various compliance and legal fees tied to entering the healthcare space, which is extremely regulated.”
Metriport has just launched Health Device API, which allows digital health companies to gain access to their users’ consumer health data from various wearables and more.
Next will be launching Medical API, which will allow companies to gain both access to their patients’ medical records and interface with EHRs, according to Elsinga.
“Both of these products are open source, which is a huge differentiator in the market,” he told TC.
The raise came at a US$20 million valuation, according to the report.